2Willemze R, Jansen P M, Cerroni L. Subcutaneous panniculitislike T cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases[J]. Blood, 2008, 111(2):838-845.
3Ronald S G, Susan M W. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma, a systematic analysis of 156 patients reported in the literature [J]. Cancer,2004, 101(6) :1404- 1413.
2Jung CK,Lee KY,Kim Y,et al. Epstein-Barr virus infection,drug resistance and prognosis in Korean T-and NK-cell lymphomas [ J ]. Pathol Int,2001,51 (5) : 355 -363.
3Salhany KE, Macon WR, Choi JK, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic and genotypic analysis of alpha/beta and gamma/delta subtypes [ J ]. Am J Surg Pathol, 1998,22(7 ) :881.
4Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature [ J]. Cancer, 2004, 101 (6):1404 - 1413.
5Takeshita M, lmayana S, Oshiro Y,et al. Clinicopathologic analysis of 22 cases of subcutaneous panniculitis-like CD567 or CD56^+ lymphoma and review of 4 other reported cases [ J ]. Am J Clin Pathol,2004,121 (3) : 408 - 416.
6Weiss LM,Jaffe ES,Liu XF,et al. Detection and localization of Epstein- Barr viral genomes in angioimmunoblastic lymphadenopathy and angio- immunoblastic lymphadenopathy-like lymphoma [ J ]. Blood, 1992,79 (7) : 1789 -1795.
7Li G,Chooback L,Wolfe J,et al. Overexpression of p53 protein in cutaneous T-cell lymphoma:relationship to large cell transformation and disease progression [ J ]. J Invest Dermatol, 1998,110 ( 5 ) : 767 - 770.
8Erkek E, Sahin S, Atakan N, et al. Examination of mycosis fungoides for thepresence of Epstein-Barr virus and humanherpesvirus-6 by polymerase chain reaction[J]. J Eur Acad Dermatol Venereol,2001,15 (5) : 422 - 426.
9Velculescu VE,EL-Deiry WS. Biological and clinical importance of the P53 tumor suppressor gene [ J ]. Clin Chem, 1996,42 ( 6 ) : 858 - 868.
10Maestro R, Gloghini A, Doglioni C, et al. MDM2 overexpression does not account for stabilization of wild-type P53 protein in non-Hodgkin's lymphoma[ J]. Blood, 1995,85 ( 11 ) : 3239 - 3246.
